Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Bd. 149. H. 9. 2023 S. 5937-5950
Erscheinungsjahr: 2023
Publikationstyp: Zeitschriftenaufsatz
| Geprüft | Bibliothek |
Autoren
Lordick, Florian (Autor)
Thuss-Patience, Peter (Autor)
Bitzer, Michael (Autor)
Maurus, Daniel (Autor)
Sahin, Ugur (Autor)
Tuereci, Oezlem (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
